• Price (EUR)74.15
  • Today's Change0.61 / 0.83%
  • Shares traded0.00
  • 1 Year change-7.03%
  • Beta--
Data delayed at least 15 minutes, as of Mar 22 2023 07:08 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Henry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental and medical practitioners. The Company’s segments include Health care distribution and Technology and value-added services. The Health care distribution segment is combining its global dental and medical businesses, distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, dental specialty products (including implant, orthodontic and endodontic products), diagnostic tests, infection-control products, personal protective equipment products (PPE) and vitamins. The Technology and value-added services segment provides software, technology and other value-added services to healthcare practitioners. The Company distributes its products from approximately 29 located distribution centers.

  • Revenue in USD (TTM)12.65bn
  • Net income in USD538.00m
  • Incorporated1992
  • Employees22.00k
  • Location
    Henry Schein Inc135 Duryea RdMELVILLE 11747United StatesUSA
  • Phone+1 (631) 843-5500
  • Fax+1 (302) 636-5454
  • Websitehttps://www.henryschein.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
HSIC:NSQ since
Biotech Dental SASAnnounced16 Dec 202216 Dec 2022Announced-3.78%--
Midway Dental Supply IncDeal completed29 Aug 202229 Aug 2022Deal completed7.66%--
Condor Dental Research Co SADeal completed07 Jun 202207 Jun 2022Deal completed-6.12%--
Data delayed at least 15 minutes, as of Mar 22 2023 19:50 BST.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.